- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
Finder makes money from featured partners, but editorial opinions are our own.
Advertiser disclosure
TG Therapeutics is a biotechnology business based in the US. TG Therapeutics shares (TGTX) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $32.20 – an increase of 0.56% over the previous week. TG Therapeutics employs 319 staff and has a trailing 12-month revenue of around $264.8 million.
What's in this guide?
Our top picks for where to buy TG Therapeutics stock
- Trade $0 commission stocks & ETFs with as little as $1
- Earn up to $300 with qualifying deposits
- Discover new opportunities with Opto's AI-driven thematic investing system
- Theme and ETF screener
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options with no options contract fees
- Get up to $1,000 in stock when you fund a new account within 30 days
- Complimentary access to a financial planner
Probability of member receiving $1,000 is 0.028%
How to buy TG Therapeutics stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – TGTX. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy TG Therapeutics stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.1 - 4 of 4
What is the Finder Score?
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
TG Therapeutics stock price (NASDAQ: TGTX)
Use our graph to track the performance of TGTX stocks over time.TG Therapeutics shares at a glance
Information last updated 2024-12-19.
| Latest market close | $32.20 |
|---|---|
| 52-week range | $12.84 - $36.84 |
| 50-day moving average | $28.79 |
| 200-day moving average | $21.21 |
| Wall St. target price | $40.75 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-0.10 |
Is it a good time to buy TG Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
TG Therapeutics price performance over time
Historical closes compared with the close of $32.2 from 2024-12-20
| 1 week (2024-12-13) | 0.56% |
|---|---|
| 1 month (2024-11-22) | -8.18% |
| 3 months (2024-09-20) | 30.63% |
| 6 months (2024-06-21) | 82.44% |
| 1 year (2023-12-22) | 89.41% |
|---|---|
| 2 years (2022-12-22) | 275.29% |
| 3 years (2021-12-22) | 75.48% |
| 5 years (2019-12-20) | 218.50% |
TG Therapeutics financials
| Revenue TTM | $264.8 million |
|---|---|
| Operating margin TTM | 14.82% |
| Gross profit TTM | $2.5 million |
| Return on assets TTM | -0.07% |
| Return on equity TTM | -8.05% |
| Profit margin | -5.43% |
| Book value | $1.34 |
| Market Capitalization | $4.8 billion |
TTM: trailing 12 months
TG Therapeutics share dividends
We're not expecting TG Therapeutics to pay a dividend over the next 12 months.
Have TG Therapeutics's shares ever split?
TG Therapeutics's shares were split on a 100:5625 basis on 29 April 2012 . So if you had owned 5625 shares the day before before the split, the next day you'd have owned 100 shares. This wouldn't directly have changed the overall worth of your TG Therapeutics shares – just the quantity. However, indirectly, the new 5525% higher share price could have impacted the market appetite for TG Therapeutics shares which in turn could have impacted TG Therapeutics's share price.
TG Therapeutics share price volatility
Over the last 12 months, TG Therapeutics's shares have ranged in value from as little as $12.84 up to $36.84. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while TG Therapeutics's is 2.193. This would suggest that TG Therapeutics's shares are significantly more volatile than the average for this exchange and represent a higher risk.
TG Therapeutics overview
TG Therapeutics, Inc. , a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally. It provides BRIUMVI, an anti-CD20 monoclonal antibody for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in adults. The company's development pipeline comprises Umbralisib, an oral inhibitor of PI3K-delta inhibitor for the treatment of adult patients with relapsed or refractory marginal zone lymphoma and follicular lymphoma; TG-1701 is an orally available and covalently bound Bruton's tyrosine kinase (BTK) inhibitor that exhibits selectivity to BTK in vitro kinase screening; and TG-1801, a bispecific CD47 and CD19 antibody. Its research pipeline includes various investigational medicines. The company has license agreements with LFB Biotechnologies S. A.
Frequently asked questions
What percentage of TG Therapeutics is owned by insiders or institutions?Currently 9.504% of TG Therapeutics shares are held by insiders and 66.392% by institutions. How many people work for TG Therapeutics?
Latest data suggests 319 work at TG Therapeutics. When does the fiscal year end for TG Therapeutics?
TG Therapeutics's fiscal year ends in December. Where is TG Therapeutics based?
TG Therapeutics's address is: 3020 Carrington Mill Blvd., Morrisville, NC, United States, 27560 What is TG Therapeutics's ISIN number?
TG Therapeutics's international securities identification number is: US88322Q1085 What is TG Therapeutics's CUSIP number?
TG Therapeutics's Committee on Uniform Securities Identification Procedures number is: 048785109
More resources on Finder
More guides on Finder
-
Best Stocks for Beginners With Little Money to Invest
These are the stocks to buy when you don’t have much to spend.
-
Sweep Accounts
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
-
Today’s Best Brokerage Account Bonuses [Signup and Transfer Promos]
Explore the best bonuses for opening a new brokerage account.
-
Trading for Beginners: 9 Best Trading Platforms to Get Started
These are the best trading platforms for beginners, according to Finder’s comprehensive analysis.
-
10 Best Stock Apps of 2024 to Elevate Your Mobile Trading
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
-
5 Top Graphene Stocks to Invest in Today
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
-
10 Best Brokerage Accounts for Trading and Investing in 2024
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
How to Invest $10K
Maximize $10,000 with broker bonuses, IRA contribution matches, index funds, stocks, ladder CDs, hiring a financial advisor and more.
-
5 best ETFs for 2024
Check out the best-performing ETFs so far in 2024.
Ask a question